Immunotherapy for melanoma
β Scribed by Lacy, Katie E; Karagiannis, Sophia N; Nestle, Frank O
- Book ID
- 118139192
- Publisher
- Expert Reviews
- Year
- 2012
- Tongue
- English
- Weight
- 714 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1746-9872
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Melanoma has traditionally been considered an immunogenic tumor. A number of approaches have been studied for enhancement of antitumor immunity. The first cytokine approved for the treatment of metastatic melanoma, interleukinβ2, has resulted in prolonged responses in a small subset of
Adjuvant immunotherapy was administered to 84 lymph-node-negative and 25 lymph-node-positive melanoma patients. This active specific homologous cell protein preparation was given after aggressive surgery and given over 2 years. Projected and observed survival rates are presented as well as other cli